Vanguard Group Inc Stoke Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,731,198 shares of STOK stock, worth $22.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,731,198

Previous 2,759,247 1.02%

Holding current value

$22.2 Million

Previous $33.9 Million 11.16%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$10.8 - $13.92 $302,929 - $390,442	-28,049 Reduced 1.02%	2,731,198 $30.1 Million
Q3 2024 Nov 13, 2024	BUY	$12.24 - $15.92 $876,249 - $1.14 Million	71,589 Added 2.66%	2,759,247 $33.9 Million
Q2 2024 Aug 13, 2024	BUY	$11.03 - $17.52 $10.7 Million - $17 Million	972,104 Added 56.66%	2,687,658 $36.3 Million
Q1 2024 May 10, 2024	BUY	$4.12 - $14.17 $276,254 - $950,126	67,052 Added 4.07%	1,715,554 $23.2 Million
Q4 2023 Feb 14, 2024	BUY	$3.37 - $5.4 $60,033 - $96,195	17,814 Added 1.09%	1,648,502 $8.67 Million
Q3 2023 Nov 14, 2023	BUY	$3.78 - $11.99 $90,357 - $286,608	23,904 Added 1.49%	1,630,688 $6.42 Million
Q2 2023 Aug 14, 2023	BUY	$7.93 - $13.82 $3.77 Million - $6.56 Million	474,797 Added 41.94%	1,606,784 $17.1 Million
Q1 2023 May 15, 2023	SELL	$7.65 - $10.38 $3.6 Million - $4.88 Million	-470,058 Reduced 29.34%	1,131,987 $9.43 Million
Q4 2022 Feb 10, 2023	SELL	$7.07 - $15.69 $3.15 Million - $7 Million	-445,859 Reduced 21.77%	1,602,045 $14.8 Million
Q3 2022 Nov 14, 2022	BUY	$12.56 - $22.53 $664,059 - $1.19 Million	52,871 Added 2.65%	2,047,904 $26.3 Million
Q2 2022 Aug 12, 2022	BUY	$10.36 - $23.93 $576,461 - $1.33 Million	55,643 Added 2.87%	1,995,033 $26.4 Million
Q1 2022 May 13, 2022	BUY	$17.19 - $26.1 $467,705 - $710,128	27,208 Added 1.42%	1,939,390 $40.8 Million
Q4 2021 Feb 14, 2022	BUY	$18.11 - $30.72 $1.17 Million - $1.98 Million	64,567 Added 3.49%	1,912,182 $45.9 Million
Q3 2021 Nov 12, 2021	BUY	$23.65 - $34.44 $2.57 Million - $3.75 Million	108,813 Added 6.26%	1,847,615 $47 Million
Q2 2021 Aug 13, 2021	BUY	$30.53 - $41.09 $53.1 Million - $71.4 Million	1,738,802 New	1,738,802 $58.5 Million

Others Institutions Holding STOK

# of Institutions

136

Shares Held

57.3M

Call Options Held

5.7K

Put Options Held

24.4K

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $320M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Stoke Therapeutics, Inc. Transaction History